Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in mice
Intragenic CpG dinucleotides are tightly conserved in evolution yet are also vulnerable to methylation-dependent mutation, raising the question as to why these functionally critical sites have not been deselected by more stable coding sequences. We previously showed in cell lines that altered exonic...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101519/?tool=EBI |
| _version_ | 1797846187351474176 |
|---|---|
| author | Richard J. Epstein Frank P. Y. Lin Robert A. Brink James Blackburn |
| author_facet | Richard J. Epstein Frank P. Y. Lin Robert A. Brink James Blackburn |
| author_sort | Richard J. Epstein |
| collection | DOAJ |
| description | Intragenic CpG dinucleotides are tightly conserved in evolution yet are also vulnerable to methylation-dependent mutation, raising the question as to why these functionally critical sites have not been deselected by more stable coding sequences. We previously showed in cell lines that altered exonic CpG methylation can modify promoter start sites, and hence protein isoform expression, for the human TP53 tumor suppressor gene. Here we extend this work to the in vivo setting by testing whether synonymous germline modifications of exonic CpG sites affect murine development, fertility, longevity, or cancer incidence. We substituted the DNA-binding exons 5–8 of Trp53, the mouse ortholog of human TP53, with variant-CpG (either CpG-depleted or -enriched) sequences predicted to encode the normal p53 amino acid sequence; a control construct was also created in which all non-CpG sites were synonymously substituted. Homozygous Trp53-null mice were the only genotype to develop tumors. Mice with variant-CpG Trp53 sequences remained tumor-free, but were uniquely prone to dental anomalies causing jaw malocclusion (p < .0001). Since the latter phenotype also characterises murine Rett syndrome due to dysfunction of the trans-repressive MeCP2 methyl-CpG-binding protein, we hypothesise that CpG sites may exert non-coding phenotypic effects via pre-translational cis-interactions of 5-methylcytosine with methyl-binding proteins which regulate mRNA transcript initiation, expression or splicing, although direct effects on mRNA structure or translation are also possible. |
| first_indexed | 2024-04-09T17:51:58Z |
| format | Article |
| id | doaj.art-d94db2c1f32b421ab9e19d69c81510aa |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-09T17:51:58Z |
| publishDate | 2023-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-d94db2c1f32b421ab9e19d69c81510aa2023-04-16T05:31:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01184Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in miceRichard J. EpsteinFrank P. Y. LinRobert A. BrinkJames BlackburnIntragenic CpG dinucleotides are tightly conserved in evolution yet are also vulnerable to methylation-dependent mutation, raising the question as to why these functionally critical sites have not been deselected by more stable coding sequences. We previously showed in cell lines that altered exonic CpG methylation can modify promoter start sites, and hence protein isoform expression, for the human TP53 tumor suppressor gene. Here we extend this work to the in vivo setting by testing whether synonymous germline modifications of exonic CpG sites affect murine development, fertility, longevity, or cancer incidence. We substituted the DNA-binding exons 5–8 of Trp53, the mouse ortholog of human TP53, with variant-CpG (either CpG-depleted or -enriched) sequences predicted to encode the normal p53 amino acid sequence; a control construct was also created in which all non-CpG sites were synonymously substituted. Homozygous Trp53-null mice were the only genotype to develop tumors. Mice with variant-CpG Trp53 sequences remained tumor-free, but were uniquely prone to dental anomalies causing jaw malocclusion (p < .0001). Since the latter phenotype also characterises murine Rett syndrome due to dysfunction of the trans-repressive MeCP2 methyl-CpG-binding protein, we hypothesise that CpG sites may exert non-coding phenotypic effects via pre-translational cis-interactions of 5-methylcytosine with methyl-binding proteins which regulate mRNA transcript initiation, expression or splicing, although direct effects on mRNA structure or translation are also possible.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101519/?tool=EBI |
| spellingShingle | Richard J. Epstein Frank P. Y. Lin Robert A. Brink James Blackburn Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in mice PLoS ONE |
| title | Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in mice |
| title_full | Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in mice |
| title_fullStr | Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in mice |
| title_full_unstemmed | Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in mice |
| title_short | Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in mice |
| title_sort | synonymous alterations of cancer associated trp53 cpg mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock in mice |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101519/?tool=EBI |
| work_keys_str_mv | AT richardjepstein synonymousalterationsofcancerassociatedtrp53cpgmutationalhotspotscausefataldevelopmentaljawmalocclusionsbutnotumorsinknockinmice AT frankpylin synonymousalterationsofcancerassociatedtrp53cpgmutationalhotspotscausefataldevelopmentaljawmalocclusionsbutnotumorsinknockinmice AT robertabrink synonymousalterationsofcancerassociatedtrp53cpgmutationalhotspotscausefataldevelopmentaljawmalocclusionsbutnotumorsinknockinmice AT jamesblackburn synonymousalterationsofcancerassociatedtrp53cpgmutationalhotspotscausefataldevelopmentaljawmalocclusionsbutnotumorsinknockinmice |